Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery
Launched by UNIVERSITY OF SASKATCHEWAN · Oct 28, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to manage pain during and after laparoscopic colorectal surgery without using traditional opioids. Researchers want to see if an opioid-free anesthesia technique, which includes medications like lidocaine, ketamine, and dexmedetomidine, can help patients recover faster and reduce the need for opioid pain relief after surgery. The goal is to help patients return to normal bowel function more quickly, which is important for a smooth recovery.
To participate in this study, you need to be at least 18 years old and scheduled for elective laparoscopic colorectal surgery. You should also be in good general health, as defined by specific guidelines. If you join the trial, you can expect to receive the opioid-free anesthesia during your procedure and be monitored closely for your recovery. This study is currently looking for participants, and it's a great opportunity to contribute to important research that may improve pain management in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18, American Society of Anesthesiology (ASA) class I-III patients scheduled for elective laparoscopic/laparoscopic assisted colorectal surgery
- Exclusion Criteria:
- • Emergency surgery, open surgery, contraindications to laparoscopic surgery (ie. adhesions, inability to tolerate pneumoperitoneum), American Society of Anesthesiology (ASA) class 4, age \< 18, pregnant or breastfeeding women, significant cardiorespiratory/hepatic/renal disease, allergy to any study drugs, inability to consent, inability to respond to pain assessments, inability to use the patient controlled analgesia device (PCA)
About University Of Saskatchewan
The University of Saskatchewan is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a commitment to improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. By fostering collaborations among researchers, healthcare professionals, and industry partners, the University of Saskatchewan aims to translate scientific discoveries into practical applications that enhance healthcare delivery and contribute to the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials